Clinical Trial Update: Venetoclax and Azacitidine Combined With Chidamide (VAC) for the Treatment of Newly Diagnosed Acute Monocytic Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the triple combination of venetoclax, azacitidine, and chidamide (VAC) for newly diagnosed acute monocytic leukemia and i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Monocytic Leukemia

Drugs mentioned

• Chidamide (chidamide)
• VIDAZA (AZACITIDINE)
• Venclexta (venetoclax)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Acute Monocytic Leukemia, Newly Diagnosed | Phase 2 | Status: RECRUITING